Benzinga | Aug 10, 2021 04:40PM EDT

ClearPoint Neuro Q2 EPS $(0.17) Misses $(0.13) Estimate, Sales $3.41M Miss $3.68M Estimate

ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.13) by 30.77 percent. This is a 54.55 percent decrease over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $3.41 million which missed the analyst consensus estimate of $3.68 million by 7.26 percent. This is a 37.73 percent increase over sales of $2.48 million the same period last year.